Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Crane

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Clinical Nuclear Medicine|January 2, 2025
Voxel-Based Dosimetry Predicts Local Tumor Progression Post 90 Y Radiation Segmentectomy of Colorectal Liver MetastasesPlaton M Dimopoulos, Vlasios S Sotirchos, Cynthia Dunne-Jaffe, et al.
Journal of the American College of Surgeons|May 22, 2012
Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative explorationMark J Truty, Ryan M Thomas, Matthew H Katz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patientsMark Bonnen, Christopher Crane, Jean-Nicolas Vauthey, et al.
Practical Radiation Oncology|April 29, 2014
Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapySam S Yoon, Thomas A Aloia, Alex B Haynes, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern eraArya Amini, Lianchun Xiao, Pamela K Allen, et al.
Annals of Surgical Oncology|June 17, 2010
Long-term survival and recurrence outcomes following surgery for distal rectal cancerEric J Silberfein, Kiran M Kattepogu, Chung-Yuan Hu, et al.
International Journal of Molecular Sciences|December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular CarcinomaPerla Chami, Youssef Diab, Danny N Khalil, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2016
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704Donghui Li, Jennifer Moughan, Christopher Crane, et al.
International Journal of Gastrointestinal Cancer|May 20, 2003
Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic CancerChristopher Crane, N Janjan, D Evans, et al.
Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Clinical Nuclear Medicine|January 2, 2025
Voxel-Based Dosimetry Predicts Local Tumor Progression Post 90 Y Radiation Segmentectomy of Colorectal Liver MetastasesPlaton M Dimopoulos, Vlasios S Sotirchos, Cynthia Dunne-Jaffe, et al.
Journal of the American College of Surgeons|May 22, 2012
Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative explorationMark J Truty, Ryan M Thomas, Matthew H Katz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patientsMark Bonnen, Christopher Crane, Jean-Nicolas Vauthey, et al.
Practical Radiation Oncology|April 29, 2014
Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapySam S Yoon, Thomas A Aloia, Alex B Haynes, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern eraArya Amini, Lianchun Xiao, Pamela K Allen, et al.
Annals of Surgical Oncology|June 17, 2010
Long-term survival and recurrence outcomes following surgery for distal rectal cancerEric J Silberfein, Kiran M Kattepogu, Chung-Yuan Hu, et al.
International Journal of Molecular Sciences|December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular CarcinomaPerla Chami, Youssef Diab, Danny N Khalil, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2016
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704Donghui Li, Jennifer Moughan, Christopher Crane, et al.
International Journal of Gastrointestinal Cancer|May 20, 2003
Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic CancerChristopher Crane, N Janjan, D Evans, et al.
Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.
Pageof 7